TWiV 99: ICAAC Boston 2010

September 19, 2010

Host: Vincent Racaniello

On episode 99 of the podcast This Week in Virology, Vincent tours the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, speaking with exhibitors and visitors, including Professors Derek Smith, Michael Schmidt, Frederick Hayden, and Myra McClure.

Many thanks to Chris Condayan and Ray Ortega of the American Society for Microbiology for recording and editing this episode.

Play

Click the arrow above to play, or right-click to download TWiV #99 (45 MB .mp3, 62 minutes)

Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, or by email, or listen on your mobile device with Stitcher Radio.

Links for this episode:

Send your virology questions and comments (email or mp3 file) to twiv@twiv.tv or leave voicemail at Skype: twivpodcast. You can also post articles that you would like us to discuss at microbeworld.org and tag them with twiv.

  • John

    This TWiV was a nice format and nicely done, Prof. Racaniello. You did a good job as usual with the questions and the video itself was very neat looking so props to the camerapersons and video editors along with the interviewer and interviewees.

  • anonymous

    A comment on the new poster technology. Having every poster available for anybody to download and take home (and send to anybody else) raises some issues. Most poster data is pre-publication and has not been vetted nor peer-reviewed. Moreover, the work may be incomplete. If anybody can take it and scrutinize it or scoop it, enthusiasm for presenting unpublished, new and exciting data may be dampened.

  • Murraythefrog22

    Right, but I think the fact that there is evidence that the owner of the poster presented the data first would protect them. If that person presents there data, and then two weeks later someone comes out with the same data, I think they would have a good case for themselves, and would the copier be penalized for academic….copyright? (i’m not sure if copyright is the correct word. Maybe just ‘academic dishonesty?)

  • Shhh

    This is not to be read on air, or even about this podcast. I should post this in TWIP, but I thought this mail would get read more often.

    Has anyone thought about microbes and sound? How they hear? Viruses can’t even in theory, but bacteria and protozoa could. They live in liquid, liquid carries vibrations. Perhaps they perceive their world like a blind man, who can tell roughly what size room he is in, not by a specific sound, but by the ‘ambience’ of the space.

    Should be easy to do some experiments, with a (little) microphone. Then try to mimic it with a (little) speaker and a signal generator.

    And objects that small can move on waves (or standing waves). Maybe baccilli “surf” right towards flagelates. Or sneak up the “baffles” like a Russian submarine on an American one.

    Also, since it flagella/cilli move at a rate that can be measured, some one could compensate for size and density and convert those sounds, so you could hear what is sounds like for a bacterium to swim by. I’m sure a single flagellum would sound different, and a spirochete would sound different from that.

    just a thought…

  • LC

    So where did McClure get her serological assay?

    http://listserv.nodak.edu/cgi-bin/wa.exe?A2=ind1009D&L=co-cure&P=R2806
    From Suzy Chapman

    28 September 2010

    Circulated on behalf of a member of the public:

    May be reposted

    FoI request to Imperial College London ref XMRV serology test

    Following Professor Myra McClure’s statement (in the Q&A session of the 1st
    International XMRV Workshop ) that “We’ve now done the serology”, a Freedom
    of Information request was submitted to Imperial College London on 10th
    September 2010 to identify whether they had developed a serology test for
    XMRV. This included the following.

    (i) Confirmation of whether Imperial College London has developed a
    serology (anti-body) test for XMRV (xenotropic murine leukaemia-related
    virus).

    (ii) If this test is for both ME (also known as CFS) and prostate cancer
    combined, or for just one of these diseases in isolation, or if there are
    separate tests for each of these diseases.

    (iii) If this test detects anti-bodies to all MLVs (murine leukaemia
    related viruses) or just XMRV.

    (iv) If this test is used for research purposes only or if it is available
    commercially or if there are plans to make it available commercially.

    (v) If this test has been developed for specific research purposes within
    Imperial College London, or other research institution, and if these
    research purposes will be published (e.g. in a science journal or on the
    college website) and when.

    (vi) How long the test has been in use (for research purposes or
    otherwise).

    The following response was received on 27th September 2010.

    “Further to your Freedom of Information request, Imperial College has not
    developed a serology (anti-body) test for XMRV and therefore the remaining
    questions (ii – vi) are not applicable.”

    ———————-

    It is unclear, therefore, which/whose XMRV serology assay is being used by
    Professor McClure and, given that it has not been developed by the Imperial
    team itself, how they are able to vouch for its reliability. If the assay
    in question has been proven empirically to detect XMRV antibodies and,
    given the growing number of UK patients who are testing positive via the
    Whittemore Peterson Institute/National Cancer Institute’s methods,
    Imperial’s continued failure to detect the retrovirus implies that either
    they have a flawed sample cohort and/or (as discussed at the 1st
    International XMRV Workshop) they could be using contaminated test tubes.

  • http://www.virology.ws profvrr

    The poster printing technology is opt-in. If you don’t want to participate, you don’t have to.

  • http://www.virology.ws profvrr

    Dr McClure did not say (at least in my ICAAC interview) that she had developed a serological assay for XMRV. She said the assay was not specific for XMRV; it was to look for xenotropic MLVs, and it was done by a collaborator at another institution. All of which may explain why Imperial College answered your FOI request as they did.

  • Anonymous

    At the XMRV conference she said they had done the serology. This is why someone decided to ask under a FOI request for clarification. I know in your interview McClure said two assays from Itzui were used, which were none specific for XMRV. I only posted the this to help explain the situation.

  • Pingback: TWiV 114: Ten out of ’10

  • Pingback: Derek Smith on antigenic cartography

  • Justin Reilly

    Prof. R.- interesting twiv- “like”-worthy as always,- nice to see you and not just hear your voice.
    you did a good job of calling ME (aka ‘CFS’)- “chronic fatigue syndrome”- only once did you drop the ‘syndrome’ and give us the dreaded “CF.” You may have noticed Prof. McClure calls it CF always- a bit of sloppiness that causes a lot of confusion. She seemed reasonable here, completely unlike her totally unprofessional and anti-scientific misrepresentations in the press when she released her flawed study.

  • Pingback: Frederick Hayden on influenza antivirals